Arcutis Biotherapeutics Inc (ARQT) USD0.0001

Sell:$9.73Buy:$9.75$0.07 (0.72%)

NASDAQ:0.81%
Market closed | Prices delayed by at least 15 minutes
Sell:$9.73
Buy:$9.75
Change:$0.07 (0.72%)
Market closed | Prices delayed by at least 15 minutes
Sell:$9.73
Buy:$9.75
Change:$0.07 (0.72%)
Market closed | Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
1 July 2024
Howard G WelgusDirector
Sell
Option/Award related
10,000$9.31$93,141.00180,339
4 June 2024
Howard G WelgusDirector
Sell
Option/Award related
3,542$8.00$28,336.00176,658
4 June 2024
Howard G WelgusDirector
Sell
Option/Award related
6,458$8.01$51,755.70170,200
30 May 2024
Patrick BurnettChief Level Officer
Sell
Option/Award related
23,000$8.75$201,319.00209,793
29 May 2024
Patrick BurnettChief Level Officer
Sell
Regular sell transaction (market)
49,952$8.72$435,386.63209,793
28 May 2024
Masaru (Mas) MatsudaCompany Secretary
Sell
Tax related
1,775$9.01$15,988.14188,508
17 May 2024
Larry Todd EdwardsChief Level Officer
Sell
Tax related
7,640$8.98$68,581.99140,360
2 May 2024
Todd Franklin WatanabePresident/CEO
Sell
Tax related
13,783$8.74$120,433.10860,750
2 May 2024
Patrick BurnettChief Level Officer
Sell
Tax related
9,555$8.74$83,489.68259,745
2 May 2024
Masaru (Mas) MatsudaCompany Secretary
Sell
Tax related
5,016$8.74$43,828.80185,408

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
29 May 2024
Patrick BurnettChief Level Officer
Sell
Regular sell transaction (market)
49,952$8.72$435,386.63209,793
30 May 2024
Patrick BurnettChief Level Officer
Sell
Option/Award related
23,000$8.75$201,319.00209,793
24 October 2023
FRAZIER LIFE SCIENCES VIII LPVenture Capital
Buy
Regular purchase transaction
80,000$2.50$200,000.008,764,232
4 March 2024
FRAZIER LIFE SCIENCES VIII LPVenture Capital
Buy
Regular purchase transaction
21,052$9.50$199,994.008,785,284
4 March 2024
Todd Franklin WatanabePresident/CEO
Sell
Option/Award related
14,903$11.12$165,739.24874,533

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.